Compare Cintas Corporation (CTAS) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cintas Corporation vs 10X Genomics Inc — how do they compare? Cintas Corporation trades at $205.28 (market cap $82.15B), while 10X Genomics Inc trades at $59.23 (market cap $7.61B). The key difference: Cintas Corporation is far larger — about 10.8× 10X Genomics Inc's market cap, and Cintas Corporation pays a 1.01% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| CTAS | TXG | |
|---|---|---|
Market Cap | $82.15B | $7.61B |
Sector | Industrials | Health |
52-Week High | $225.10 | $58.57 |
52-Week Low | $163.55 | $11.34 |
Enterprise Value | $84.56B | $7.14B |
Dividend Yield | 1.01% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cintas Corporation
In its core uniform and facility services unit (78% of sales), Cintas provides uniform rental programs to businesses across the size spectrum, mostly in North America. The firm is by far the largest provider in the industry. Facilities products generally include the rental and sale of entrance mat, mops, shop towels, hand sanitizers, and restroom supplies. Cintas also runs a first aid and safety services business (11% of sales), a fire protection services business (7% of sales), and a uniform direct sales business (4% of sales).
Read more on CTAS →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
